Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists
Although not currently supported by high-level evidence, serum E2 monitoring is widely adopted in clinical practice. Prospective studies and evidence-based recommendations are urgently needed. Emerging strategies to overcome incomplete OFS include LHRH antagonists (e.g., degarelix) and oral SERDs.
Authors
- Giuseppe Curigliano (ORCID: https://orcid.org/0000-0003-1781-2518)
- Dario Trapani (ORCID: https://orcid.org/0000-0003-1672-9560)
- Elisabetta Munzone (ORCID: https://orcid.org/0000-0003-3371-3878)
- Carmine Valenza (ORCID: https://orcid.org/0000-0003-1150-0345)
- Gabriella Pravettoni (ORCID: https://orcid.org/0000-0002-4843-4663)
- Julian Etessami
Institutions
- University of Milan (IT)
- European Institute of Oncology (IT)
Publication Details
- Journal
- Current Opinion in Oncology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1097/cco.0000000000001191
- Citations
- 1
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 1.82